Dr. Eric Edison Low, MD, MPH

Dr. Low practices at UCSD Hillcrest Medical Center in San Diego, California.

Dr. Low's NPI, 1245761766, was assigned on March 26, 2017. Dr. Low graduated from UCSF School of Medicine in 2017. Dr. Low holds California license A160707.

Dr. Low's primary practice is UCSD Hillcrest Medical Center, at 200 W Arbor Dr, San Diego, CA 92103 in San Diego County. The practice phone is (619) 543-6222.

Dr. Low's primary practice is UCSD Hillcrest Medical Center in San Diego, California. Dr. Low is also affiliated with Hillcrest Medical Center. The medical group on file is UC San Diego Health.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Low practices. Vendor and product names are available with a free account.

Gastroenterology is Dr. Low's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Low is board certified in gastroenterology by the American Board of Internal Medicine. Dr. Low is licensed in California.

Dmand AI lists acid reflux, colonoscopy and upper GI endoscopy among the conditions Dr. Low treats.

CMS data shows 103 Medicare services from Dr. Low across 3 procedure codes in 2024, for 104 Medicare patients. Medicare paid $12,553 for them.

CMS counts 104 Medicare patients who saw Dr. Low in 2024. The largest group is 65 to 74, with 45 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 39% are also on Medicaid. Their average risk score is 2.47, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Low's median patient age at 54, with 55% women.

In 2024, Dr. Low wrote 238 Medicare Part D claims for 99 patients. 85% of them were for generic drugs. CMS names the drug for 188 of them, across 7 drugs with 11 or more claims each, at $10,543 in total drug cost. In 2023, CMS named 49 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Low for performance year 2024, reported as part of a group. Dr. Low accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Low as offering telehealth. CMS counts 89 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Low, more than 74% of the clinicians it reports for that procedure.

Dmand AI links 28 papers to Dr. Low, published from 2014 to 2024. 2023 was the busiest year, with 11. The most frequent topics are Esophageal Achalasia, Manometry and Esophagogastric Junction. Dr. Low has published most often in Neurogastroenterol Motil. Dr. Low's most frequent co-authors are Syed M.a. Fehmi, MD, MS, Samir Gupta, MD and Aws Kamal Hasan.

CMS Open Payments shows 13 general payments to Dr. Low from 5 drug and device companies from 2021 to 2025. Food and beverage make up the largest share, 97% of the total. Takeda Pharmaceuticals U.S.A., Inc. paid the most, $202. It also lists 6 research payments totaling $3,825 from 2024 to 2025, naming 1 clinical trial.

Dr. Low graduated from UCSF School of Medicine in 2017.

Dr. Low is in network with 15 carriers, including Blue Cross Blue Shield of Michigan, Elevance and United Healthcare. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.